TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion
暂无分享,去创建一个
M. Rubin | A. Chinnaiyan | C. Collins | J. Mosquera | F. Demichelis | A. D. De Marzo | S. Perner | J. Simko | M. Hofer | P. Paris | T. Bismar
[1] Y Pawitan,et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort , 2007, Oncogene.
[2] Ximing J. Yang,et al. A Working Group Classification of Focal Prostate Atrophy Lesions , 2006, The American journal of surgical pathology.
[3] J. Tchinda,et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.
[4] P. Febbo,et al. Defining aggressive prostate cancer using a 12-gene model. , 2006, Neoplasia.
[5] I. Panagopoulos,et al. Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. , 2006, Genes, chromosomes & cancer.
[6] A. Evans,et al. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. , 2006, Neoplasia.
[7] Lennart Franzén,et al. How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden. , 2006, The Journal of urology.
[8] Arul M Chinnaiyan,et al. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. , 2006, Cancer research.
[9] A. Jemal,et al. Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.
[10] M. Rubin,et al. Prognostic factors in lymph node-positive prostate cancer. , 2005, Urology.
[11] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[12] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[13] Debashis Ghosh,et al. Decreased α-Methylacyl CoA Racemase Expression in Localized Prostate Cancer is Associated with an Increased Rate of Biochemical Recurrence and Cancer-Specific Death , 2005, Cancer Epidemiology Biomarkers & Prevention.
[14] V. Srikantan,et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2005, Oncogene.
[15] Mark A Rubin,et al. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. , 2004, Human pathology.
[16] Jaime Pujadas Oláno,et al. Natural history of early localized prostate cancer. , 2004, JAMA.
[17] W. Sellers,et al. Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer , 2004, Cancer Research.
[18] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. , 2003, Journal of the National Cancer Institute.
[19] J. Hicks,et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. , 2003, The American journal of pathology.
[20] J. Trent,et al. α-methylacyl-CoA racemase: A new molecular marker for prostate cancer , 2002 .
[21] Debashis Ghosh,et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.
[22] J. Trent,et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. , 2002, Cancer research.
[23] R. Shah,et al. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? , 2001, The American journal of pathology.
[24] F. Mitelman,et al. Recurrent chromosome aberrations in cancer. , 2000, Mutation research.
[25] J. Epstein,et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.
[26] L. Holmberg,et al. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. , 1997, JAMA.
[27] T. Triche,et al. The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.
[28] L. Holmberg,et al. High 10-year survival rate in patients with early, untreated prostatic cancer. , 1992, JAMA.
[29] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.